BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 22902503)

  • 21. Adaptation by naïve CD4
    Zinzow-Kramer WM; Weiss A; Au-Yeung BB
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15160-15169. PubMed ID: 31285342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.
    Gauld SB; Benschop RJ; Merrell KT; Cambier JC
    Nat Immunol; 2005 Nov; 6(11):1160-7. PubMed ID: 16200069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice.
    Loh C; Pau E; Chang NH; Wither JE
    Eur J Immunol; 2011 Feb; 41(2):527-36. PubMed ID: 21268021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells.
    Schwickert TA; Tagoh H; Schindler K; Fischer M; Jaritz M; Busslinger M
    Nat Immunol; 2019 Nov; 20(11):1517-1529. PubMed ID: 31591571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal Development of Mature B Cells Requires Recognition of Endogenous Antigens.
    Noviski M; Tan C; Huizar J; Vykunta V; Mueller JL; Zikherman J
    J Immunol; 2019 Jul; 203(2):418-428. PubMed ID: 31167773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionally responsive self-reactive B cells of low affinity express reduced levels of surface IgM.
    Kirchenbaum GA; St Clair JB; Detanico T; Aviszus K; Wysocki LJ
    Eur J Immunol; 2014 Apr; 44(4):970-82. PubMed ID: 24375379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy.
    Cook MC; Basten A; Fazekas de St Groth B
    J Exp Med; 1997 Aug; 186(5):631-43. PubMed ID: 9271579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracing Self-Reactive B Cells in Normal Mice.
    Nojima T; Reynolds AE; Kitamura D; Kelsoe G; Kuraoka M
    J Immunol; 2020 Jul; 205(1):90-101. PubMed ID: 32414809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
    Chen Z; Krinsky A; Woolaver RA; Wang X; Chen SMY; Popolizio V; Xie P; Wang JH
    J Immunol; 2020 Aug; 205(3):830-841. PubMed ID: 32591397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of T cell autoreactivity to MHC class II by controlling CD80 (B7-1) expression on B cells.
    Hasegawa A; Ueno Y; Yamashita M; Nakayama T; Tada T
    Int Immunol; 1998 Feb; 10(2):147-58. PubMed ID: 9533442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance.
    Minguet S; Kläsener K; Schaffer AM; Fiala GJ; Osteso-Ibánez T; Raute K; Navarro-Lérida I; Hartl FA; Seidl M; Reth M; Del Pozo MA
    Nat Immunol; 2017 Oct; 18(10):1150-1159. PubMed ID: 28805811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.
    Tan C; Mueller JL; Noviski M; Huizar J; Lau D; Dubinin A; Molofsky A; Wilson PC; Zikherman J
    J Immunol; 2019 May; 202(10):2907-2923. PubMed ID: 30962292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.
    Finney J; Watanabe A; Kelsoe G; Kuraoka M
    Immunol Rev; 2019 Nov; 292(1):24-36. PubMed ID: 31559648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homeostasis and self-tolerance in the immune system: turning lymphocytes off.
    Van Parijs L; Abbas AK
    Science; 1998 Apr; 280(5361):243-8. PubMed ID: 9535647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
    Bonami RH; Thomas JW
    J Immunol; 2015 Nov; 195(10):4730-41. PubMed ID: 26432895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.